Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Clinuvel Pharma Stock News

CLVLYOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$7.10

0.010000.14%

At close: -

$7.05

-0.05-0.70%

After Hours: Feb 12, 9:05 AM EDT

Clinuvel Pharma (CLVLY) Forecast

News

Earnings Clinuvel Pharma (CLVLY) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Clinuvel Pharma Stock News | OTC:CLVLY | Benzinga

Get the latest news on Clinuvel Pharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Clinuvel Pharma performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, March 24, 2020

Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights - Mar 24, 2020, 11:35AM

Friday, February 28, 2020

Stocks That Hit 52-Week Lows On Friday
Lisa Levin - Feb 28, 2020, 10:16AM

Thursday, February 27, 2020

Stocks That Hit 52-Week Lows On Thursday
Lisa Levin - Feb 27, 2020, 10:23AM

Wednesday, February 26, 2020

Stocks That Hit 52-Week Lows On Wednesday
Lisa Levin - Feb 26, 2020, 11:14AM

Sunday, October 13, 2019

The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings
Shanthi Rexaline - Oct 13, 2019, 4:33PM

Wednesday, October 09, 2019

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin - Oct 9, 2019, 11:05AM
The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
Shanthi Rexaline - Oct 9, 2019, 7:58AM

Tuesday, October 08, 2019

The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration
Shanthi Rexaline - Oct 8, 2019, 7:11AM

Sunday, October 06, 2019

The Week Ahead In Biotech: Pfenex And Clinuvel On The Radar Ahead of FDA Decisions, 2 IPOs On Deck
Shanthi Rexaline - Oct 6, 2019, 5:15PM

Monday, September 30, 2019

Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates
Shanthi Rexaline - Sep 30, 2019, 4:32PM

Tuesday, July 29, 2014

Benzinga's M&A Chatter for Monday July 28, 2014
Benzinga - Jul 28, 2014, 8:04PM

Sunday, July 27, 2014

Clinuvel Pharmaceuticals Receives Unsolicite...
Benzinga - Jul 27, 2014, 7:53PM

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved